Results
Senores Pharmaceuticals FY26 Revenue Up 65.3% YoY
Senores Pharmaceuticals reported 65.3% YoY revenue growth to ₹401.7 Cr in FY26, driven by 90.6% growth in regulated markets.
The company completed acquisitions of Zoraya Pharmaceuticals and 75% of Apn
